• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Extrinsic pathway inhibitor in postoperative/posttraumatic septicemia: increased levels in fatal cases.

作者信息

Sandset P M, Røise O, Aasen A O, Abildgaard U

机构信息

Medical Department, Aker Hospital, Oslo, Norway.

出版信息

Haemostasis. 1989;19(4):189-95. doi: 10.1159/000215916.

DOI:10.1159/000215916
PMID:2807038
Abstract

The activity of the extrinsic pathway inhibitor (EPI), which is the factor-Xa-dependent inhibitor of the factor VIIa-tissue thromboplastin complex, was serially determined in 13 patients with postoperative/posttraumatic septicemia, and compared to the activity of antithrombin (AT), heparin cofactor II and protein C (PC). In the survivors (n = 8), initial low values for all the inhibitors normalized during recovery. In the demises (n = 5), a progressive increase in EPI activity was observed until death, whereas progressive decreases were observed for the other inhibitors. No correlation was found between the inhibitor values and the endotoxin concentration. We conclude that EPI activities are increased in the late course of fatal septicemia. Apparently, a large EPI-AT gap is a severe prognostic indicator in such patients.

摘要

相似文献

1
Extrinsic pathway inhibitor in postoperative/posttraumatic septicemia: increased levels in fatal cases.
Haemostasis. 1989;19(4):189-95. doi: 10.1159/000215916.
2
Extrinsic pathway inhibitor--the key to feedback control of blood coagulation initiated by tissue thromboplastin.外源性途径抑制剂——组织凝血活酶启动的血液凝固反馈控制的关键。
Haemostasis. 1991;21(4):219-39. doi: 10.1159/000216231.
3
The inhibitor of F VIIa in plasma measured with a sensitive chromogenic substrate assay: comparison with antithrombin, protein C and heparin cofactor II in a clinical material.用灵敏的发色底物分析法测定血浆中F VIIa抑制剂:与临床样本中的抗凝血酶、蛋白C和肝素辅因子II的比较
Folia Haematol Int Mag Klin Morphol Blutforsch. 1988;115(3):274-7.
4
The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic pathway inhibitor and fibrinopeptide A in systemic meningococcal disease.
Thromb Res. 1989 Aug 15;55(4):459-70. doi: 10.1016/0049-3848(89)90054-6.
5
Released granulocytic elastase: an indicator of pathobiochemical alterations in septicemia after abdominal surgery.释放的粒细胞弹性蛋白酶:腹部手术后败血症病理生化改变的一个指标。
Surgery. 1985 Nov;98(5):892-9.
6
Antithrombin-mediated inhibition of factor VIIa-tissue factor complex by the synthetic pentasaccharide representing the heparin binding site to antithrombin.通过代表肝素与抗凝血酶结合位点的合成五糖,抗凝血酶介导对因子VIIa-组织因子复合物的抑制作用。
Thromb Haemost. 1996 Jul;76(1):5-8.
7
Antithrombin III, heparin cofactor and antifactor Xa in relation to age, sex and pathological condition.抗凝血酶III、肝素辅因子与抗Xa因子水平与年龄、性别及病理状况的关系
Haemostasis. 1980;9(5):297-302. doi: 10.1159/000214368.
8
Optimization of a coagulation factor VIIa inhibitor found in factor Xa inhibitor library.在Xa因子抑制剂库中发现的凝血因子VIIa抑制剂的优化
Bioorg Med Chem. 2005 Mar 1;13(5):1487-96. doi: 10.1016/j.bmc.2004.12.033.
9
Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.体外循环期间高剂量肝素化监测——凝血酶原酶诱导凝血时间(PiCT)与两种发色底物法抗Xa因子活性测定的比较
Thromb Haemost. 2008 Feb;99(2):427-34. doi: 10.1160/TH07-04-0307.
10
Selective inhibition of factor Xa is more efficient than factor VIIa-tissue factor complex blockade at facilitating coronary thrombolysis in the canine model.
J Am Coll Cardiol. 1996 Dec;28(7):1858-65. doi: 10.1016/S0735-1097(96)00401-9.

引用本文的文献

1
Sepsis-induced coagulation in the baboon lung is associated with decreased tissue factor pathway inhibitor.狒狒肺部脓毒症诱导的凝血与组织因子途径抑制物减少有关。
Am J Pathol. 2007 Sep;171(3):1066-77. doi: 10.2353/ajpath.2007.070104. Epub 2007 Jul 19.
2
Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study.抗凝血酶III(ATIII)替代疗法用于脓毒症和/或术后并发症患者:一项对照双盲、随机、多中心研究。
Intensive Care Med. 1998 Apr;24(4):336-42. doi: 10.1007/s001340050576.
3
Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.
组织因子途径抑制剂可降低大肠杆菌感染性休克的死亡率。
J Clin Invest. 1993 Jun;91(6):2850-60. doi: 10.1172/JCI116529.
4
AT III in septicemia with DIC.败血症合并弥散性血管内凝血时的抗凝血酶III
Intensive Care Med. 1993;19 Suppl 1:S16-8. doi: 10.1007/BF01738945.
5
Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: evidence supporting a physiologic role for EPI as a natural anticoagulant.外源性途径抑制剂(EPI)的缺失使家兔对组织因子诱导的弥散性血管内凝血敏感:支持EPI作为天然抗凝剂发挥生理作用的证据。
Proc Natl Acad Sci U S A. 1991 Feb 1;88(3):708-12. doi: 10.1073/pnas.88.3.708.